|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C07K 16/18 | (2006.01) | ||
| A61K 31/385 | (2006.01) | ||
| A61K 31/337 | (2006.01) | ||
| A61K 33/24 | (2019.01) | ||
| A61K 31/506 | (2006.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 39/395 | (2006.01) |
| (11) | Number of the document | 2947098 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15166232.7 |
| Date of filing the European patent application | 2009-10-29 | |
| (97) | Date of publication of the European application | 2015-11-25 |
| (45) | Date of publication and mention of the grant of the patent | 2019-11-20 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 226910 P | 2009-07-20 | US | |
| 462168 | 2009-07-30 | US | |
| PCT/US2009/0522 | 2009-07-30 | WO |
| (72) |
LEE, Francis, Y., US
JURE-KUNKEL, Maria, US
|
| (73) |
Bristol-Myers Squibb Company,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
|
| (54) | COMBINATION OF ANTI-CTLA4 ANTIBODY WITH GEMCITABINE FOR THE SYNERGISTIC TREATMENT OF PROLIFERATIVE DISEASES |
| COMBINATION OF ANTI-CTLA4 ANTIBODY WITH GEMCITABINE FOR THE SYNERGISTIC TREATMENT OF PROLIFERATIVE DISEASES |